Cargando…

Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions

PURPOSE: This work aimed to longitudinally assess the peripapillary (PPCT) and subfoveal (SFCT) choroidal thickness (CT), in patients diagnosed with central (CRVO) or branch retinal vein occlusions (BRVO), correlating SFCT with central macular thickness (CMT) and PPCT with peripapillary retinal nerv...

Descripción completa

Detalles Bibliográficos
Autores principales: Moleiro, Ana Filipa, Godinho, Gonçalo, Madeira, Carolina, Faria Pereira, Ana, Brandão, Elisete, Falcão-Reis, Fernando, Beato, João Nuno, Penas, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675997/
https://www.ncbi.nlm.nih.gov/pubmed/36415602
http://dx.doi.org/10.2147/OPTH.S379373
_version_ 1784833494044639232
author Moleiro, Ana Filipa
Godinho, Gonçalo
Madeira, Carolina
Faria Pereira, Ana
Brandão, Elisete
Falcão-Reis, Fernando
Beato, João Nuno
Penas, Susana
author_facet Moleiro, Ana Filipa
Godinho, Gonçalo
Madeira, Carolina
Faria Pereira, Ana
Brandão, Elisete
Falcão-Reis, Fernando
Beato, João Nuno
Penas, Susana
author_sort Moleiro, Ana Filipa
collection PubMed
description PURPOSE: This work aimed to longitudinally assess the peripapillary (PPCT) and subfoveal (SFCT) choroidal thickness (CT), in patients diagnosed with central (CRVO) or branch retinal vein occlusions (BRVO), correlating SFCT with central macular thickness (CMT) and PPCT with peripapillary retinal nerve fiber layer thickness (pRNFL). PATIENTS AND METHODS: This was a retrospective longitudinal study of 71 eyes from 71 patients with treatment-naïve retinal vein occlusion (24 CRVO and 40 BRVO). Spectral-domain optical coherence tomography (SD-OCT, Spectralis HRA-OCT, Heidelberg) was used to measure PPCT, SFCT, pRNFL and CMT of the affected and fellow eyes at baseline (acute phase) and at 3 and 9 months post anti-VEGF treatment. IBM SPSS Statistics version 27.0 (IBM Corp., Armonk, NY, USA) was used for statistical analysis. A p-value ≤0.05 was considered statistically significant. RESULTS: Affected eyes presented a thicker baseline PPCT and SFCT compared to their fellow eyes both in CRVO and BRVO (p < 0.05). Both groups presented a significant decrease of PPCT in the affected eyes at 3 months compared to baseline (p < 0.05). At 9 months, compared to 3 months, PPCT remained stable (p > 0.05). Similarly, affected eyes’ SFCT significantly decreased at 3 months (p < 0.05) in both groups. At 9 months, compared to 3 months, SFCT decreased in the CRVO patients (p = 0.047) but remained stable in the BRVO patients (p = 0.850). No correIations between SFCT and CMT were seen at any timepoint in both groups (p > 0.05). PPCT correlates with pRNFL in CRVO at 3 months, although no other correlations were found during the follow-up. In BRVO, PPCT did not show any significant correlation with pRNFL. CONCLUSION: Both in CRVO and BRVO eyes, PPCT and SFCT at diagnosis are significantly thicker compared to the fellow eye, suggesting a possible increase in CT immediately after the occlusion, which is followed by a decrease at an early follow-up stage.
format Online
Article
Text
id pubmed-9675997
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-96759972022-11-21 Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions Moleiro, Ana Filipa Godinho, Gonçalo Madeira, Carolina Faria Pereira, Ana Brandão, Elisete Falcão-Reis, Fernando Beato, João Nuno Penas, Susana Clin Ophthalmol Original Research PURPOSE: This work aimed to longitudinally assess the peripapillary (PPCT) and subfoveal (SFCT) choroidal thickness (CT), in patients diagnosed with central (CRVO) or branch retinal vein occlusions (BRVO), correlating SFCT with central macular thickness (CMT) and PPCT with peripapillary retinal nerve fiber layer thickness (pRNFL). PATIENTS AND METHODS: This was a retrospective longitudinal study of 71 eyes from 71 patients with treatment-naïve retinal vein occlusion (24 CRVO and 40 BRVO). Spectral-domain optical coherence tomography (SD-OCT, Spectralis HRA-OCT, Heidelberg) was used to measure PPCT, SFCT, pRNFL and CMT of the affected and fellow eyes at baseline (acute phase) and at 3 and 9 months post anti-VEGF treatment. IBM SPSS Statistics version 27.0 (IBM Corp., Armonk, NY, USA) was used for statistical analysis. A p-value ≤0.05 was considered statistically significant. RESULTS: Affected eyes presented a thicker baseline PPCT and SFCT compared to their fellow eyes both in CRVO and BRVO (p < 0.05). Both groups presented a significant decrease of PPCT in the affected eyes at 3 months compared to baseline (p < 0.05). At 9 months, compared to 3 months, PPCT remained stable (p > 0.05). Similarly, affected eyes’ SFCT significantly decreased at 3 months (p < 0.05) in both groups. At 9 months, compared to 3 months, SFCT decreased in the CRVO patients (p = 0.047) but remained stable in the BRVO patients (p = 0.850). No correIations between SFCT and CMT were seen at any timepoint in both groups (p > 0.05). PPCT correlates with pRNFL in CRVO at 3 months, although no other correlations were found during the follow-up. In BRVO, PPCT did not show any significant correlation with pRNFL. CONCLUSION: Both in CRVO and BRVO eyes, PPCT and SFCT at diagnosis are significantly thicker compared to the fellow eye, suggesting a possible increase in CT immediately after the occlusion, which is followed by a decrease at an early follow-up stage. Dove 2022-11-16 /pmc/articles/PMC9675997/ /pubmed/36415602 http://dx.doi.org/10.2147/OPTH.S379373 Text en © 2022 Moleiro et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Moleiro, Ana Filipa
Godinho, Gonçalo
Madeira, Carolina
Faria Pereira, Ana
Brandão, Elisete
Falcão-Reis, Fernando
Beato, João Nuno
Penas, Susana
Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions
title Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions
title_full Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions
title_fullStr Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions
title_full_unstemmed Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions
title_short Peripapillary and Subfoveal Choroidal Thickness in Retinal Vein Occlusions
title_sort peripapillary and subfoveal choroidal thickness in retinal vein occlusions
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675997/
https://www.ncbi.nlm.nih.gov/pubmed/36415602
http://dx.doi.org/10.2147/OPTH.S379373
work_keys_str_mv AT moleiroanafilipa peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions
AT godinhogoncalo peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions
AT madeiracarolina peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions
AT fariapereiraana peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions
AT brandaoelisete peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions
AT falcaoreisfernando peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions
AT beatojoaonuno peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions
AT penassusana peripapillaryandsubfovealchoroidalthicknessinretinalveinocclusions